We are live on ! Find out more
STSA

Satsuma Pharmaceuticals, Inc. Common Stock

Delisted

STSA was delisted on the 7th of June, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$24.5M
CC
2
Commodore Capital
New York
$15.4M
NMC
3
NEA Management Company
Maryland
$13M
SC
4
Samlyn Capital
New York
$12.2M +$526K +149,046 +5%
TGA
5
TPG GP A
Texas
$7.81M
VC
6
Vivo Capital
California
$5.1M
Ameriprise
7
Ameriprise
Minnesota
$3.14M +$18K +5,108 +0.7%
IC
8
Ikarian Capital
Texas
$2.7M
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.65M -$28.1K -7,968 -1%
Morgan Stanley
10
Morgan Stanley
New York
$1.02M +$826K +234,307 +1,892%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$979K +$58.8K +16,671 +8%
Barclays
12
Barclays
United Kingdom
$838K
Geode Capital Management
13
Geode Capital Management
Massachusetts
$682K +$206K +58,368 +55%
Walleye Capital
14
Walleye Capital
New York
$627K -$389K -110,385 -42%
Citadel Advisors
15
Citadel Advisors
Florida
$624K -$122K -34,656 -19%
NFGH
16
Nan Fung Group Holdings
Hong Kong
$592K
BlackRock
17
BlackRock
New York
$568K +$11K +3,109 +2%
BCM
18
Bridgeway Capital Management
Texas
$527K +$35.3K +10,000 +9%
BFM
19
Boothbay Fund Management
New York
$268K
JP Morgan Chase
20
JP Morgan Chase
New York
$195K +$166K +46,998 New
State Street
21
State Street
Massachusetts
$178K
Northern Trust
22
Northern Trust
Illinois
$157K -$2.9K -823 -2%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$156K -$102K -29,000 -44%
Norges Bank
24
Norges Bank
Norway
$73.3K
UBS Group
25
UBS Group
Switzerland
$73K +$53.3K +15,127 +613%